Quagliarello V J, Scheld W M
Am J Med Sci. 1986 Nov;292(5):306-9. doi: 10.1097/00000441-198611000-00010.
Bacterial meningitis continues to account for worldwide morbidity and mortality despite the advent of effective bactericidal antibiotic therapy. Recent advances over the past 10 years in the development of experimental animal models as well as basic investigation into critical bacterial surface virulence factors have begun to clarify a conceptual framework for understanding the mechanism of meningitis development in humans. Basic observations regarding competing host defenses and bacterial virulence factors have supported a pathogenetic sequence of mucosal colonization with a meningeal pathogen; systemic host invasion with intravascular replication; blood brain barrier penetration and unimpeded CSF proliferation amid the impaired host defenses in the CSF milieu; and pathophysiologic sequelae including vasogenic, cytotoxic, and interstitial brain edema (and other processes) accounting for irreversible neuronal injury and death. Only through continued basic investigation into each of these pathogenetic steps will significant reductions in morbidity and mortality ensue.
尽管有效的杀菌抗生素疗法已经问世,但细菌性脑膜炎仍然是全球发病和死亡的原因。在过去10年中,实验动物模型的开发以及对关键细菌表面毒力因子的基础研究取得了进展,这开始为理解人类脑膜炎发病机制阐明了一个概念框架。关于宿主防御和细菌毒力因子相互作用的基础观察结果支持了以下发病机制顺序:脑膜病原体在黏膜定植;病原体通过血管内复制进行全身侵袭;在脑脊液环境中宿主防御受损的情况下突破血脑屏障并在脑脊液中不受阻碍地增殖;以及包括血管源性、细胞毒性和间质性脑水肿(以及其他过程)在内的病理生理后遗症,这些后遗症导致不可逆的神经元损伤和死亡。只有通过对这些发病机制的每一步进行持续的基础研究,才能显著降低发病率和死亡率。